SLS

Apegg

Seeing a lot of chatter about SLS.  Looks like a binary biotech play.  Any thoughts?

ooqua

😂go all in on SLS🚀

ooqua

go all in on SLS🚀

the_infamous_walrus

I posted about SLS forever ago. (Not a penny) but also archer at $9. Posted about HIT at $0.80. Posted about MDAI still moving up. Just actually read the dd and do your own. There are still people posting about real growth potential companies. Someone posted about NUAI @ $0.48 I biught $1000 and sold because I got weak hands but just got to did through the trash and you’ll find the gold. Posted about PFSA before they had a 150% move the day before and got downvoted into oblivion. PBM and CGEN are still sleeper companies.

Valuable_Glove_5084

Why not SLS? Sounds better than fake meat.

stevenryl866

SLS - added when 13g out, BlackRock increased position

emptyminds0110

Doing great. SLS survived and gapping up after market. INTC leaps doing fine.

ImaginationBroad2590

SLS This stock has been manipulated by shorts for a long time but they couldn’t hold below the $2 price today. As a result, 41,000 $2 calls were in the money helping with a mini gamma squeeze that ran up about $0.80 after hours. Major event on the 29th, I think we may see $10-$12 share price by the end of the month

emptyminds0110

$SLS in summary: SLS’s late stage REGAL trial of GPS (galinpepimut-S) is a survival-based study. Final results will be analyzed once 80 patient deaths occur across both groups, the GPS treatment arm and the control arm (placebo or standard therapy). As of January 2025, the company had reached about 80% of that target, meaning around 60 events. By now, it’s expected they will hit the full 80 events by December, triggering the final data readout. That readout will show whether GPS improves overall survival (OS) compared to the control. It will also include details on safety and subgroup results, making it a key “binary” event for the stock.

Ok-Print-1906

SLS taking off……to be continued on Monday

steadyeddy_10

Buying SLS

emptyminds0110

Here's a few tickers: (1) Calls for Jan/April-2026 for SLS - December binary events. $10-$50+ move possible. Why: read their Jan-2025 news on phase 3 GSP:) (2) QURE price target $120, buy leap calls or equity now. (3) CLOV leaps 2027. Price target $20+ (4) PFE - equity or leap calls. (5) INTC leap calls 2026 for $48-55 strike or load the equity. The above suggestion is valid until tomorrow friday evening. Good luck

EffectiveSlacker

SLS might be the play of the week for u

BIGGUSDIKKUSFAN

SLS

Old_Buffalo_5980

Thoughts on SLS?

InterestingMinute972

SLS going to go mental soon. Runup already began

islandmonkey99

Good luck! this seems a little too risky to my taste. But i just bought SLS which just started launching (hopefully). 🫡

EffectiveSlacker

SLS will do well tonight. Trust

tempest_36

SLS

EffectiveSlacker

Do consider FMST and SLS

borjan13

Thoughts on SLS?

KreativeHawk

Anyone in SLS? Thinking of taking a position as a gamble, essentially seems like a 2 month maximum coin flip with decent odds on positive Phase 3 results.

Mickey302

I 2nd SLS!

Theflyingdutchman85

SLS

C3POmeetsR2D2

SLS calling, not BUBU - HUHU - MUMU

Prestigious-Duck-189

I currently own over 26k shares. Not all-in but it’s a substantial portion of my portfolio. It’s biotech so the risk is binary but the outlook for SLS is incredible so I decided to make this the play of a lifetime.

Prestigious-Duck-189

SLS Late stage biotech with incredible interim results and now about the release final analysis. Possibly during the R&D day on the 29th. Two products in the pipeline and so far both look like they’re about to change the cancer treatment landscape. Their product GPS is basically derisked if you do the math. Current PPS is not even close to where it should be due to warrant conversions and manipulation but when results are released (before EOY according to the CEO) we should see one of the craziest upticks of the year here. Simply check out the SLS subreddit as it has great and knowledgeable people providing DD for a long time already. I personally expected a final analysis and buyout way sooner but patients keep on living here 💪🏼

Prestigious-Duck-189

Late stage biotech with incredible interim results and now about the release final analysis. Possibly during the R&D day on the 29th. Two products in the pipeline and so far both look like they’re about to change the cancer treatment landscape. There product GPS is basically derisked if you do the math. Current shareprice is not even close to where it should be due to warrant conversions and manipulation but when results are released (before EOY according to the CEO) we should see one of the craziest upticks of the year here. Simply check out the SLS subreddit as it has great and knowledgeable people providing DD for a long time already. I personally expected a final analysis and buyout way sooner but patients keep on living here 💪🏼

Prestigious-Duck-189

SLS is going to rocket this month. It started yesterday

Next-Environment199

Im pretty sure SLS will be releasing trial results tomorrow morning, its risky but most people think it will be positive so that could be a play

Prestigious-Duck-189

SLS

Valuable_Glove_5084

I wish SLS was on the list. But any day now, and whatnot.

_pack_a_punch_

What are your thoughts on SLS

Crazy_Reporter_7516

Someone tell me I’m a dumbass Intelc $50 Jan APLD $35 Jan SLS $4 Jan

the_infamous_walrus

SLS - going to be addressing their REGAL trials I believe at the end of the month. Already did a previous DD on them. If you want to make money. Buy and be patient.

DyatAss

If you’re looking for a biotech gamble $SLS will be releasing phase 3 results soon for a cancer drug.

timee_bot

View in your timezone: [October 29th at 10:00 AM ET][0] [0]: https://timee.io/20251029T1400?tl=SLS

Zezimama

SLS

suxmycholine

you know how you guys always complain no one says anything before something sky rockets? well here you go: $SLS do your own DD but it's all out there

DegenerateMunkee

SLS

InterestingMinute972

SLS. Buyout news imminent.

InterestingMinute972

Guys any of you in on SLS? What are the odds of a buyout there? I have had idle money in there for a long time now

thepoisonpoodle

ORKA, MBOT, BGSF, SLS ORKA short term play Bgsf until 30. September

sibeliusfan

It’s a 120 meter tall rocket that literally landed itself on the fucking tower it launched from.. like bro come on. The SLS costs about 10x more and does fuck all

Lazy_Inflation_6035

SLS is gonna go nuts when we get the data. 

the_infamous_walrus

HIT is profitable. They have already moved a lot though. Most pennies aren’t profitable hence the high risk high reward attractiveness of them. SLS, MDAI, PFSA is what I’m in. PFSA should be noted seems to have a bad reputation here from back in June. But they seem legit and just announced integration of AI utilizing NVIDIA chips to streamline data workflow for the doctors. So take this one with a grain of salt. MDAI and SLS buy the fuck out of.

the_infamous_walrus

Idk 🤷‍♂️ I’m not a crystal ball. I’m also in SLS and MDAI and it’s a game a patience. With this one maybe earnings, but otherwise I’m just being patient because I have a gut feeling there’s more than meets the eye with this one and the above slight analysis included. There’s a reason I only threw 5k at this one and have 20k in SLS and 10k in MDAI. I invest based on my confidence in the company’s growth potential. Or fall potential. Still invested but less of a sure thing to me as the others.

Over_Director_3171

In this for the long run OVID ABCL and SLS if anyone wants to hop on never say nobody didn’t warn yall ahead of time

AlejoV1553

I'm in CAN and SLS

the_infamous_walrus

SLS - you’re welcome

daryl1689

Buy 2027 $1 or $2 calls in SLS , potential to 50x you money is there

PopUsed2884

SLS has phase 3 trial finishing anytime between now and end of December.

DyatAss

Gambling on a bio-tech microcap wish me luck $SLS

Prestigious-Duck-189

SLS, yes!! Buyout happening within two quarters, probably North of $60,- per share if you do the detailed math. Currently still hovering south of $2,-. Opportunity of a lifetime of you ask me. The only thing this thing needs is the PR everyone is expecting.

PopUsed2884

Some DD on Shkreli and SLS if you’re interested https://www.reddit.com/r/sellaslifesciences/s/QNSXiZPyFn

slapstick15

Martin Shkreli is short SLS and hes mostly right so I will pass.

PopUsed2884

I feel ya, biotech can definitely burn ya if you’re not careful (even if you are careful it’s still a gamble). With that said I’m feeling pretty damn confident on their upcoming drug GPS. If you do some DD on it and the trial currently going on I think you might come to same conclusion as me. I am about 80-90% sure this drug is getting approved and SLS is launching.

PopUsed2884

SLS if your interested in biotech. They have phase 3 trial finishing anytime between now and December and it’s looking like their drug is gonna be a hit. 10x would be on the low end

Juhanialainen

Sellas Life Sciences $SLS. Thank me later. 6 months’ hold, and you’re golden.

steadyeddy_10

SLS

Klutzy_Cucumber_4139

Thanks a lot for the info, i wil take a look at SLS 👍

krispy_krmemes

SLS is the play!!

ShaeAubrey83

SLS and BTAI look especially interesting with near term catalysts

DrewSheep

IXHL and CGTX holder. Considering ELTP or SLS to portfolio.

soupbot

I do invest solely in penny biotechs, especially late stage phase 2+3 bios. You can easily tell which ones are good and which ones are bad by reading their own PR, and interrogating past clinical trials of the same drug when available, or their own phase 2+3 data when they've published it. The only ticker at this time I'd say is a good play is SLS. Their phase 2 clinical data was published here: [https://pmc.ncbi.nlm.nih.gov/articles/PMC5812332/](https://pmc.ncbi.nlm.nih.gov/articles/PMC5812332/) Demonstrating a huge increase over placebo for overall survival rate. Will it make it through phase 3? I'd say there's a good chance, but to be realistic phase 2 clinical results can fail to be repeated in phase 3. It happens. You have to be realistic about these things that while I think it's a good bet, nothing is guaranteed. I am not promising the moon or incredible valuations, that will come after phase 3 demonstrates that it meets its primary endpoint which is increased overall survival rate. You also have to take into account that passing phase 3 is itself not a guarantee of receiving FDA approval. If they don't feel the data is good they'll issue a clear response letter which kills the whole thing because it means that SLS would have to repeats its phase 3 trials. So I would say it's a smart play. There's no shell game being played with their PR where they point to irrelevant statistics as being excellent. The phase 2 clinical trial was published in a timely fashion showing the outstanding results.

PapaCharlie9

September wouldn't be weird, since every monthly cycle will have September expirations, since like I said, the **front (current) month** and the **next month** are always listed. So regardless of which cycle the stock is in, all monthly expiration option series will have both August and September expirations. It's what happens after September that determines the cycle. If October is listed, it's JAJO **unless** SLS also has quarterlies, since October is a quarterly month. If you remove October and the next listing is November, that pretty much nails down the cycle to FMAN.

Rare-Dragonfruit-246

Thanks, the stock is SLS it doesn't have a dec option, i don't think it ever did. so i think its' JAJO . but it also has a November and September options which is weird.

the_infamous_walrus

SLS - the gradual climb before the explosion is here

the_infamous_walrus

SLS - FDA approval filing event about to happen. Starting to climb. I grabbed myself 10k shares 😅🫡

No-Alternative-5533

Anyone has any input on Sellas - SLS ?

icantdodrugsanymore

!Banbet SLS 2.00 30d

DrewSheep

My play: SLS, BTAI, CTM, IXHL(believe run to 70c before reverse split)

uuuuuuuu98

$SLS. Thats it. Thats the post.

uuuuuuuu98

What about SLS ?

Paininthesky

I am once again saying SLS and DVLT

Prestigious-Duck-189

SLS, lifetime opportunity. Derisked biotech, still discounted share price due to shorts but science says it all. Buyout in Q4 is imminent.

ShamWowGuy

SLS has the most ridiculous chart I've ever seen. WTF is that?

Paininthesky

SLS just had a great announcement and can be bought a a discount.

JamesIIIVVVV

$SLS phase 3 Top line results incoming any day

cuntysometimes

SLS got me balls deep

Temporumdei

SLS has two products that treat AML, a very aggressive form of Cancer. The first product, GPS, is now at the tail end of a Phase 3 study, which compares its efficacy against the current therapies, where each month the result is delayed, the better the results are for GPS. The study was estimated to end originally by June but it was extended because it has not reached its 80th event, the binary event, that will point to a possible successful trial. The second product, SLS009, which just released data for its Phase 2 study, shows promising results, for it treats AML patients, who are resistant to the current therapies and increases the patient's overall survival. This drug is designated as fast track and may receive accelerated approval. Since it treats a population that is resistant to current therapies, it will most likely be the standard of care once it is approved for an unmet population. The reason why it is a heavy call to put ratio is due to two expectations: a binary event/result that will put GPS and SLS to revolutionize AML treatment, second, the expectation that the company will be immediately bought out. The catalyst can occur anytime from now to January, which can catapult its price overnight, because the stock currently has a short position that can cause a squeeze to cover its share. As for why the stock price is low, some argue that MMs are slowly accumulating and suppressing price discovery, using a combination of warrants and synthetic short positions to keep the stock range bound between 1.50-2.15.

Orange_Codex

Holding CHRS, SLS, and MBOT, but otherwise in T-bills this month. Something's spooky in small-cap markets; pennies are being starved of volume.

Neat-Detail7774

SLS

tomleach8

Anyone wondering what happened to SLS, my limit filled this morning :)

Orange_Codex

A $20k wager isn't worth $20k. Allowed to chill in a dividend fund, it actually becomes c. $313,000 over twenty years (if you reinvest the dividend). So, you're laying $313k on the table. Knowing that, do you still want to invest in SLS?

monsieur_feu

I was in SLS until today. I find their drug promising, but their current phase will probably take until December for any good news to come out of it. Might see ups and downs, but I’ll re-enter at a later date personally.

randolfstcosmo

SLS

Prestigious-Ant-7210

What do you think of the delay on the phase 3 results? Could be because the drug is performing very well so patients are living but not so well that they can terminate the study early, could also be that the control group is doing unexpectedly well (which is awesome, but not for SLS).

the_infamous_walrus

I have gotten HIT @0.89 IXHL @0.35 and shit I even yolo’d $200 in HCTI @0.0246 SLS is next. But I guess I gotta lose at some point right? 🤷‍♂️

the_infamous_walrus

I posted a solid dd on it a month ago. With the new bill and it’s effects on medicaid this company and TPA insurances will become the norm for hospitals. Even without the bill this was a solid company now I’m holding long term at least a year because my capital gains tax will be so high. Also get in on $SLS. I’ll post dd either tonight, probably tomorrow, but holy shit talk about the a slam dunk bio company.

the_infamous_walrus

$SLS

AffectionateGrand825

Hopefully no reverse split. SLS may dilute shareholders soon (they need cash), and cancer vaccines like GPS have historically struggled in late-phase trials. But the SLS009 program alone could carry the company, even if GPS stumbles.

DepartureAnxious5115

The IV on options for these things is insane, companies like SLS are potentially out there. I haven't done the DD but I have seen posts talking about expectations on some sort of announcement in Q3 so Oct options aren't a total mess there at a glance. Have to hand it to you, you are a special level of degen gambler and I fucking love it.

the_infamous_walrus

SLS about to get past phase 3 trials of their cancer drugwoth more in the pipeline. People invested in this drug in 2020 and it went up to $15 and it is now finally moving through the pipeline. I just got in at $1.84 see yall on the moon 🫡

Strydor

Just for those who are thinking of investing here (I have a position at 1000 shares), The Good: 1. Expected catalyst with Phase 3 data for GPS (the main drug) 2. Orphan drug designation for SLS-009, Rare Pediatric Disease Designation for both GPS and SLS-009 3. The Phase 3 REGAL trial data to come out at 80 patient deaths (GPS), the shares previous tumbled because the trial was taking longer than expected due to extended survival rates. The Bad: 1. Warrants, dilutive financing overhang. 2. High short interest (26% today) 3. 13-G/F on Fintel shows companies like Anson Funds, Citadel, Susquehanna. While it's possible to moon on buyout news or positive trial news, I'd temper expectations here. Don't expect another IXHL with this financial structure.

Orange_Codex

Just sold some fresh $IXHL profit now that the support has failed; it's probably going to $SLS.

Wuzzyup

$SLS has a lot more potential than a 5x...

Father_of_Lies666

Hey! I love SLS! A lot actually.

Electrical_Ad_828

I am in the hunt for a long-term biotech hold. Not flipping them at all as I have learnt expensive lessons. KLTO, SLS, ICU are in my list.

Serasul

SLS too